Locoregional lymph nodes are routinely examined in order to define the spatial extent of neoplastic disease. As draining patterns of certain tumor types can be divergent from expected anatomical distribution, it is critical to sample the lymph nodes truly representing the draining area. The aim of this bicenter prospective pilot study was to describe the technique of computed tomographic (CT)-lymphography for primary draining lymph node mapping in tumor staging in dogs. Fortyfive dogs with macro-or microscopic tumors in specified localizations were evaluated. Depending on body weight, 0.8-2 ml contrast agent (iohexol) was injected into four quadrants around the tumor, and CT-images were obtained at 1, 3, 6, 9, and 12 minutes post-injection. Attenuation of chosen regions of interest (Hounsfield units (HU)) and patterns of enhancement were assessed for 284 lymph nodes in the precontrast study with median HUs of 31.1 (Interquartile range (IQR) = 18.4) and for 275 in the intravenous postcontrast study with 104.3 HU (IQR = 31.2) (paired Wilcoxon test, P < 0.001). In the CT-lymphography study, 45 primary draining lymph nodes with a significantly higher median HU value of 348.5 (IQR = 591.4) (one-sample t-test, P < 0.001) were identified. Primary draining lymph nodes were found to be clearly visible after 1-3 minutes after local injection, often concurrent with a good visibility of the lymphatic vessel system. The herein described technique of peritumorally injected CT-contrast agent followed by subsequent CT-lymphography for primary draining lymph node mapping works well in a majority of cases in all investigated sites and warrants further validation for different tumor entities.
INTRODUCTION
Evaluation of the locoregional lymph nodes in order to examine the spatial extent of neoplastic disease is a routinely performed procedure in oncological tumor staging. 1 The extent of disease influences prognosis and guides accurate treatment decisions. In general, cytologic or histologic examinations of draining lymph nodes are performed for assessment of neoplastic involvement. 1, 2 However, lymphatic draining patterns of certain tumor types, such as oral malignant melanoma or mast cell tumors are often divergent from the expected anatomical lymph node, [3] [4] [5] [6] or subsequent lymph nodes are involved as well, as often found in anal sac gland adenocarcinoma, requiring additional investigation. 4, [7] [8] [9] Clinical staging hence requires sampling of the correct lymph node(s) representing the draining area of the tumor. This is ideally performed by minimally invasive techniques, to avoid excessive procedures such as complete (diagnostic) regional lymphadenectomy of lymph nodes potentially free of metastatic spread.
For certain diseases in human cancer patients (e.g. mammary tumors and malignant melanoma) the technique of sentinel lymph node mapping and sampling has proven to be effective. 10 Hereby, the "sentinel" lymph node is defined as the lymph node(s) receiving direct drainage from the tumor site. 11 The sentinel lymph node is evaluated and used for further therapeutic decision making. If such a sentinel lymph node is free of neoplastic spread, further lymph nodes can safely be assumed to be nonmetastatic and neither sampling nor removal is required.
Vet Radiol Ultrasound. 2018;59:155-162.
c 2017 American College of Veterinary Radiology 155 wileyonlinelibrary.com/journal/vru Advanced nuclear imaging techniques for lymph node mapping are available and routinely used in human oncology, 11, 12 including lymphoscintigraphy, single photon emission CT/CT, 18 Computed tomographic-lymphography has been recently reported to be an effective, noninvasive method for sentinel lymph node mapping in a group of 576 human patients affected by breast cancer. In this study, sentinel lymph nodes and their draining tracts were visualized in 99.8% and 96%, respectively. 13 The use of noninvasive sentinel lymph node mapping techniques were strongly advocated in veterinary medicine, 9 and in the last few years some studies combining lymphoscintigraphy and peritumoral injection of methylene blue dye have been published. 4, 14 Furthermore, contrast agent-related techniques for lymph node identification useful in a clinical oncologic setting have been prior described experimentally and clinically in animals, including indirect lymphography and contrast ultrasound. [15] [16] [17] [18] [19] [20] Normal dogs were initially used as a model to test the feasibility of mammary CT-lymphography for breast cancer in humans with good success and this technique has recently been shown to have a diagnostic value in the detection of metastasis in dogs with mammary tumors. 21, 22 However, little attention has been paid to this nonradioactive, simple, and fast technique for tumor staging of different anatomical sites in dogs.
We hypothesized that CT-lymphography will visualize primary draining lymph nodes of macro-or microscopic tumors in different localizations (head and neck, trunk, limbs) in dogs. These lymph nodes could be equal to anatomic lymph nodes or different, representing aberrant tumor drainage. The aim of the present research is to describe the procedure of CT-lymphography for primary draining lymph node mapping in tumor staging in dogs.
MATERIALS AND METHODS

Patients
The study was a bicenter-, prospective pilot design. for subject inclusion and exclusion were made by the senior radiologist (F.R.) or senior oncologist (C.R.B.) of the respective site. repeated. The CT scan length was set to ensure coverage of the primary tumor site and the areas of the next anatomical and up to the presumed third-tier lymph nodes. 24 Scans were acquired at 1, 3, 6, 9, and 12 minutes after the end of local injection. 
CT-study
Image analysis
Enhancement pattern of the lymphatic vessels (not assessable vs.
stagnant, dilated, or detoured lymph vessel). 10 For better identification of the pathways of the lymphatic vessels, additional multiplanar and maximum intensity projection reformatted images were created.
The assessments of both institutions were under the responsibility of one observer (M.K.). In questionable cases, the decisions were made based on consensus of five observers (F.R., M.K., J.S., G.C., C.R.B.).
Lymph node grouping and assessment
A lymph node was defined "anatomical," if the node is reported as normally draining a particular anatomical region. 6 A lymph node was defined as "primary draining," if the node was identified for receiving node to the primary draining, or another distant lymph node) ( Table 1) .
The lymph nodes' association with cytological sampling was evaluated
TA B L E 1
The lymph nodes in a certain area can be considered "anatomical" (LN(anat)) or "primary draining" (LN(primary draining))
LN(primary draining) yes LN(primary draining) no
LN(anat) yes A B LN(anat) no C D
Notes. An overlap is possible, for example an anatomical closest lymph node might also be the primary draining node. This results in four distinct groups (A-D) of node allocation.
where available. For groups A-D, the enhancement pattern in lymphatic vessels as well as the primary draining lymph nodes were evaluated and compared to subsequent cyto-or histopathological findings. For the staging accuracy between LN (primary draining) versus LN (anatomical), cytological sampling was attempted in all anatomical as well as primary draining nodes (at least up to the second-tier) using CT-or ultrasound-guidance.
Cytological assessment was made on hematoxylin-eosin stained slides by a board-certified veterinary pathologist. For this study, slides were considered to be of adequate diagnostic quality in case of a high cell yield of nucleated cells and minimal amount of cellular disruption.
Immunocytochemical examination was performed where required to corroborate diagnosis. For cases with subsequent dissection of the lymph node (at surgical excision), the lymph nodes were cut into single sections, stained with hematoxylin-eosin and further immunohistochemical staining procedures were chosen with respect to the primary tumor's histologic origin. 
Statistics
RESULTS
Patients
Forty-five dogs met inclusion criteria for the study; no patients had 
Computed tomographic lymphography technique
The planned amount of contrast agent could be injected in all but one patient, where the tumor was in the metacarpal area and only 1.2 ml of the planned 2 ml could be injected. Observed side effects attributable to an injection per se (e.g. small bleeding at site, small hematoma) were not found, but in two dogs an allergy-like local reaction (swelling) to the contrast agent was seen at the end of the study. These side effects regressed completely within 1-2 hours after subcutaneous application of an antihistaminic treatment (clemastine 0.05 mg/kg).
Contrast enhancement and pattern findings
Baseline Table 2 .
In brief, if a lymph node was identified as "primary draining" as of subjective observation, an enhancement was usually in the range of 348. and incomplete in 29 cases (64.4%). Sixty-nine enhancing lymph vessels were found and all patterns were described to be smooth and uniform.
Lymph node grouping and assessment
Forty-five primary draining lymph nodes were identified in 27/45 dogs (60%) via CT-lymphography and 18 dogs (40%) did not have identifiable primary draining lymph nodes with the described technique.
While in 77.7% the primary draining lymph nodes corresponded to the anatomical lymph node(s) ( Table 3 , Group A), 12 dogs (26.7%) had multiple draining nodes ( Figure 3 ) and in 22.3%, the primary draining node did not correspond to the anatomically closest lymph node (Table 3, Group C). (D) is neither the anatomical nor primary draining lymph node (e.g. could be a second-or third-tier lymph node to the primary draining, or another distant lymph node).
of sampled lymph nodes were positive (n = 11) and whereas only 12.8% of Group D (neither primary draining nor anatomic), revealing a significantly higher risk of positivity in Group A (Chi 2 -test, P = 0.027).
However, of the six positive lymph nodes identified as Group D lymph nodes, four of the preceding lymph nodes were cytologically positive and one lymph node could not be sampled. In this regard, these nodes represent direct downstream metastasis into a second-tier node.
In one case, the primary draining nodes were negative, indicating a skip metastasis into this unrelated Group D lymph node. The amount of enhancement (HU) did not indicate the cytological positivity or negativity of a primary draining node at any of the time-points.
DISCUSSION
The herein described technique of peritumorally injected CT-contrast agent was technically feasible with negligible injection-induced side effects. The subsequent CT-lymphography for primary draining lymph node mapping revealed a set of clearly distinguishable draining lymph nodes and lymphatic vessels in the majority of patients. Primary draining lymph nodes were found to be clearly visible after 1-3 minutes after local injection, often concurrent with a good visibility of the lymphatic vessel system. While in many cases the primary draining corresponded to the anatomical lymph node(s), about one fourth of all patients had multiple draining nodes or the primary draining node did not correspond to the anatomically closest lymph node, warranting further validation of the technique for different tumor entities.
A mapping of the lymphatic system that drains a tumor site into the primary draining lymph nodes is commonly used for staging of cancer. Several, often site-or tumor-specific techniques are described with high sensitivity and specificity for certain diseases in humans. 11 In general, a tracer substance is injected at the site of the primary tumor and subsequently followed by various imaging techniques or under direct visualization in order to identify the lymphatic collectors of the respective tumor site.
Radioactive tracer techniques are rather labor intense and not readily usable. However, they are described to work for certain tumor types and sites in animals as well. 4, 9, 14 However, the involvement of radioactive substances with essential radiation safety drug and patient handling issues as well as cost of equipment presents a limitation for certain veterinary facilities. Furthermore, the procedure is described to be a multidisciplinary approach and accuracy largely depends on the expertise of the specialists performing the procedure. 25 The simpler technique of CT-lymphography was briefly used in dog mammary tissue as a preliminary pilot study in order to establish CT-lymphography for breast cancer in women and its prognostic value could recently be shown to detect metastasis in dogs with mammary tumors. 21, 22 Our aim herein was to properly establish and describe the method of CTlymphography for different sites in the dog and we were able to show that the technique works well in the explored tumors and sites. The primary draining lymph nodes are fast and clearly visible 1-3 minutes after local injection, often in combination with a good visibility of the lymphatic vessel system. As observed in the above-mentioned pilot study in canine mammary tissue, enhancement was dependent on the amount of injected contrast agent. 22 shape, and heterogeneous enhancement of post-i.v. contrast. 27 Local injection of iodinated contrast agent lead to local side effects such as inflammation, swelling, discomfort for a few dogs. This complication has been described in humans to be rare in frequency and in case of occurrence mild and temporary, if less than 10 ml are injected. 28 Only with large amounts of extravasation of contrast agent, especially of higher osmolality (25-50 ml in man), severe local complications such as skin and subcutaneous tissue necrosis are eventually reported in humans. [29] [30] [31] Due to differences in injector pump design at the two institutions, the brand and exact osmolality of i.v. contrast medium was different but care was taken to use the most similar concentration.
Statistically no differences in the HU measurements of postcontrast studies could be found between the institutions. Another limitation was that the definition of "anatomical" lymph nodes was used broadly herein, as appropriate from an oncologist's view of tumor staging. For sites such as rostral head for example, both sides of the mandibular as well as medial retropharyngeal lymph node beds were considered "anatomical." 6 Hence, the overlap of "anatomical" and "primary draining lymph nodes" (Group A) was high (77.7%). A further caveat to be considered is that the strong enhancement of the locally injected contrast agent caused an imaging artifact over the lymph node for some cases, primarily if the primary tumor and site of injection was in very close proximity to the lymph node to be evaluated. It was observed in a few of the herein reported cases that this local injection artifact as well as accumulated contrast agent in the draining lymph node slightly distorted node size, shape, and echogenicity in subsequent ultrasound
examinations. This could be of clinical relevance if ultrasound is used for fine needle sampling.
In conclusion, the herein described technique of peritumorally injected CT-contrast agent followed by subsequent CT-lymphography was a feasible method for primary draining lymph node mapping at all 
